Anaesthesiological aspects of electroconvulsive therapy;Anästhesiologische aspekte bei elektrokrampftherapie

Anaesthesist

Volumn 56, Issue 3, 2007, Pages 202-211

  Grundmann, U ^a   Oest, M ^a  

^a SAARLAND UNIVERSITY   (Germany)

Author keywords

Anaesthesia; Electroconvulsive therapy; Hypnotics; Muscle relaxants; Psychiatric disorders

Indexed keywords

DIAZEPAM; ESMOLOL; ETOMIDATE; GLYCERYL TRINITRATE; HYPNOTIC AGENT; KETAMINE; LABETALOL; METHOHEXITAL; MIDAZOLAM; MIVACURIUM; MUSCLE RELAXANT AGENT; NICARDIPINE; NIFEDIPINE; NITROPRUSSIDE SODIUM; PROPOFOL; SEVOFLURANE; SUXAMETHONIUM; THIOPENTAL;

ANESTHESIA; ANESTHESIOLOGICAL TECHNIQUES; CLINICAL EXAMINATION; ELECTROANESTHESIA; ELECTROCARDIOGRAM; ELECTROCONVULSIVE THERAPY; ELECTROSTIMULATION; HEART CYCLE; HEMODYNAMIC MONITORING; HUMAN; MENTAL DISEASE; MUSCLE RELAXATION; PREMEDICATION; REVIEW; ST SEGMENT;

ANESTHESIA; ANESTHETICS; DEPRESSIVE DISORDER; ELECTROCONVULSIVE THERAPY; HUMANS; HYPNOTICS AND SEDATIVES; MUSCLE RELAXANTS, CENTRAL; PATIENT ACCEPTANCE OF HEALTH CARE;

EID: 33947525596     PISSN: 00032417     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00101-007-1140-x     Document Type: Review

References (67)

1. Abrams R (1990) Termination of ECT-induced prolonged seizures. Convuls Ther 6: 54-58
2. American Psychiatric Association (ed) (2001) A task force report on the practice of electroconvulsive therapy: recommendations for treatment, training, and privileging, 2nd edn. American Psychiatric Association, Washington DC
3. Andersen FA, Arsland D, Holst-Larsen H (2001) Effects of combined methohexitone-remifentanil anaesthesia in electroconvulsive therapy. Acta Anaesthesiol Scand 45: 830-833
4. Applegate RJ (1997) Diagnosis and management of ischemic heart disease in the patient scheduled to undergo electroconvulsive therapy. Convuls Ther 13: 128-144
5. Avramov MN, Husain MM, White PF (1995) The comparative effects of methohexital, propofol, and etomidate for electroconvulsive therapy. Anesth Analg 81: 596-602
6. Baghai TC, Marcuse A, Brosch M et al. (2006) The influence of concomitant antidepressant medication on safety, tolerability and clinical effectiveness of electroconvulsive therapy. World J Biol Psychiatry 7: 82-90
7. Bailine SH, Petrides G, Doft M, Lui G (2003) Indications for the use of propofol in electroconvulsive therapy. J ECT 19: 129-132
8. Beale MD (1998) Stimulus dosing methods in electroconvulsive therapy. Psychiatr Ann 28: 510-511
9. Bolwig TG, Hertz MM, Paulson OB et al. (1977) The permeability of the blood-brain barrier during electrically induced seizures in man. Eur J Clin Invest 7: 87-93
10. Calarge CA, Crowe RR (2004) Electroconvulsive therapy in myasthenia gravis. Ann Clin Psychiatry 16: 225-227
11. Cerletti U, Bini L (1938) L'Electroshock. Arch Gen Neuro Psychiatr Psychoanal 19: 266-268
12. Cheam EW, Critchley LA, Chui PT et al. (1999) Low dose mivacurium is less effective than succinylcholine in electroconvulsive therapy. Can J Anaesth 46: 49-51
13. Cockey GH, Conti CR (1995) Electroconvulsive therapy-induced transient T-wave inversions on ECG. Clin Cardiol 18: 418-420
14. Cook A, Stevenson G, Scott AI (2000) A survey of methohexitone use by anesthetists in the clinical practice of ECT in Edinburgh. J ECT 16: 350-355
15. Ding, Z, White PF (2002) Anesthesia for electroconvulsive therapy. Anesth Analg 94: 1351-1364
16. Dinwiddie SH, Isenberg KE (1995) Combined alfentanil-methohexital anesthesia in electroconvulsive therapy. Convuls Ther 11: 170-176
17. Dolinski SY, Zvara DA (1997) Anesthetic considerations of cardiovascular risk during electroconvulsive therapy. Convuls Ther 13: 157-164
18. Folk JW, Kellner CH, Beale MD et al. (2000) Anesthesia for electroconvulsive therapy: a review. J ECT 16: 157-170
19. Folkerts H, Bender S, Erkwoh R et al. (1996) Entwurf einer Stellungnahme der DGPPN zur Elektrokrampftherapie. Nervenarzt 67: 509-514
20. Folkerts H, Remschmidt H, Saß H et al. (2003) Bekanntmachungen: Stellungnahme zur Elektrokrampftherapie (EKT) als psychiatrische Behandlungsmaßnahme. Dtsch Arztebl 100: A504-A506
21. Francis A, Fochtmann L (1994) Caffeine augmentation of electroconvulsive seizures. Psychopharmacology 115: 320-324
22. Fredman B, Husain MM, White PF (1994) Anaesthesia for electroconvulsive therapy: use of propofol revisited. Eur J Anaesthesiol 11: 423-425
23. Freese KJ (1985) Can patients safely undergo electroconvulsive therapy while receiving monoamine oxidase inhibitors? Convuls Ther 1: 190-194
24. Frey R, Schreinzer D, Heiden A, Kasper S (2001) Einsatz der Elektrokrampftherapie in der Psychiatrie. Nervenarzt 72: 661-676
25. Fu W, Stool LA, White PF, Husain MM (1997) Acute hemodynamic responses to electroconvulsive therapy are not related to the duration of seizure activity. J Clin Anesth 9: 653-657
26. Gazdag G, Kocsis N, Tolna J, Ivanyi Z (2004) Etomidate versus propofol for electroconvulsive therapy in patients with schizophrenia. J ECT 20: 225-229
27. Geretsegger C, Rochowanski E, Kartnig C, Unterrainer AF (1998) Propofol and methohexital as anesthetic agents for electroconvulsive therapy (ECT): a comparison of seizure-quality measures and vital signs. J ECT 14: 28-35
28. Gerring JP, Shields HM (1982) The identification and management of patients with a high risk for cardiac arrhythmias during modified ECT. J Clin Psychiatry 43: 140-143
29. Herriot PM, Cowain T, McLeod D (1996) Use of vecuronium to prevent suxamethonium-induced myalgia after ECT. Br J Psychiatry 168: 653-654
30. Hill GE, Wong KC, Hodges MR (1976) Potentiation of succinylcholine neuromuscular blockade by lithium carbonate. Anesthesiology 44: 439-442
31. Hoenig J, Chaulk R (1977) Delirium associated with lithium therapy and electroconvulsive therapy. Can Med Assoc J 116: 837-838
32. Hoffmann-Richter U, Alder B, Finzen A (1998) Die Elektrokrampftherapie und die Defibrillation in der Zeitung. Nervenarzt 69: 622-628
33. Ishihara K, Sasa M (1999) Mechanism underlying the therapeutic effects of electroconvulsive therapy (ECT) on depression. Jpn J Pharmacol 80: 185-189
34. Ishikawa T, Kawahara S, Saito T et al. (2001) Anesthesia for electroconvulsive therapy during pregnancy - a case report. Masui 50: 991-997
35. Klecha D, Legler M, Hüll M (2002) Zur Behandlung depressiver Störungen mit modernen Verfahren der Elektrokonvulsionstherapie. Fortschr Neurol Psychiatr 70: 353-367
36. Kramer BA (1985) Use of ECT in California, 1977-1983. Am J Psychiatry 142: 1190-1192
37. Kramer BA (1993) Anticholinergics and ECT. Convuls Ther 9: 293-300
38. Lapid MI, Rummans TA, Hofmann VE, Olney BA (2001) ECT and automatic internal cardioverter-defibrillator. J ECT 17: 146-148
39. Lopez-Gomez D, Sanchez-Corral MA, Cobo JV et al. (1999) Myocardial infarction after electroconvulsive therapy. Rev Esp Cardiol 52: 536
40. Lui PW, Ma JY, Chan KK (1993) Modification of tonic-clonic convulsions by atracurium in multiplemonitored electroconvulsive therapy. J Clin Anesth 5: 16-21
41. MacPherson RD, Loo CK, Barrett N (2006) Electroconvulsive therapy in patients with cardiac pacemakers. Anaesth Intensive Care 34: 470-474
42. Mathe AA (1999) Neuropeptides and electroconvulsive treatment. J ECT 15: 60-75
43. Mayur PM, Gangadhar BN, Girish K et al. (1998) Acute post-ECT cardiovascular response: a comparison of threshold right unilateral and bilateral ECT. J ECT 14: 94-98
44. Möllenberg O (1997) Elektrokrampftherapie - Anästhesiologisches Vorgehen. Anasthesiol Intensivmed Notfallmed Schmerzther 32: 593-603
45. Mokriski BK, Nagle SE, Papuchis GC et al. (1992) Electroconvulsive therapy-induced cardiac arrhythmias during anesthesia with methohexital, thiamylal, or thiopental sodium. J Clin Anesth 4: 208-212
46. Naguib M, Koorn R (2002) Interactions between psychotropics, anaesthetics and electroconvulsive therapy: implications for drug choice and patient management. CNS Drugs 16: 229-247
47. Newman ME, Gur E, Shapira B, Lerer B (1998) Neurochemical mechanisms of action of ECS: evidence from in vivo studies. J ECT 14: 153-171
48. Nguyen TT, Chhibber AK, Lustik SJ et al. (1997) Effect of methohexitone and propofol with or without alfentanil on seizure duration and recovery in electroconvulsive therapy. Br J Anaesth 79: 801-803
49. Nishihara F, Saito S (2002) Pre-ictal bispectral index has a positive correlation with seizure duration during electroconvulsive therapy. Anesth Analg 94: 1249-1259
50. Ochiai R, Yamada T, Kiyama S et al. (2004) Bispectral index as an indicator of seizure inducibility in electroconvulsive therapy under thiopental anesthesia. Anesth Analg 98: 1030-1035
51. Otsuka H, Shikama H, Saito T et al. (2000) Asystole during electroconvulsive therapy in a patient with depression and myasthenia gravis. Masui 49: 893-895
52. Rasmussen KG, Spackman TN, Hooten WM (2005) The clinical utility of inhalational anesthesia with sevoflurane in electroconvulsive therapy. J ECT 21: 239-242
53. Rasmussen KG, Zorumski CF (1993) Electroconvulsive therapy in patients taking theophylline. J Clin Psychiatry 54: 427-431
54. Saffer S, Berk M (1998) Anesthetic induction for ECT with etomidate is associated with longer seizure duration than thiopentone. J ECT 14: 89-93
55. Saito S (2005) Anesthesia management for electroconvulsive therapy: hemodynamic and respiratory management. J Anesth 19: 142-149
56. Sarpel Y, Togrul E, Herdem M et al. (1996) Central acetabular fracture-dislocation following electroconvulsive therapy: report of two similar cases. J Trauma 41: 342-344
57. Sauer H, Laschka E, Stillenmunkes HP, Lauter H (1987) Elektrokrampftherapie in der Bundesrepublik Deutschland. Nervenarzt 58: 519-522
58. Stern L, Dannon PN, Hirschmann S et al. (1999) Aminophylline increases seizure length during electroconvulsive therapy. J ECT 15: 252-257
59. Szuba MP, O'Reardon JP, Evans DL (2000) Physiological effects of electroconvulsive therapy and transcranial magnetic stimulation in major depression. Depress Anxiety 12: 170-177
60. Tang WK, Ungvari GS (2001) Asystole during electroconvulsive therapy: a case report. Aust N Z J Psychiatry 35: 382-385
61. Trollor JN, Sachdev PS (1999) Electroconvulsive treatment of neuroleptic malignant syndrome: a review and report of cases. Aust N Z J Psychiatry 33: 650-659
62. Broek WW van den, Leentjens AF, Mulder PG et al. (1999) Low-dose esmolol bolus reduces seizure duration during electroconvulsive therapy: a double-blind, placebo-controlled study. Br J Anaesth 83: 271-274
63. Viguera A, Rordorf G, Schouten R et al. (1998) Intracranial haemodynamics during attenuated responses to electroconvulsive therapy in the presence of an intracerebral aneurysm. J Neurol Neurosurg Psychiatry 64: 802-805
64. Wagner KJ, Möllenberg O, Rentrop M et al. (2005) Guide to anesthetic selection for electroconvulsive therapy. CNS Drugs 19: 745-758
65. Wajima Z, Shiga T, Yoshikawa T et al. (2003) Propofol alone, sevoflurane alone, and combined propofol-sevoflurane anaesthesia in electroconvulsive therapy. Anaesth Intensive Care 31: 396-400
66. Welch CA, Drop LJ (1989) Cardiovascular effects of ECT. Convuls Ther 5: 35-43
67. Zielinski RJ, Roose SP, Devanand DP et al. (1993) Cardiovascular complications of ECT in depressed patients with cardiac disease. Am J Psychiatry 150: 904-990